Morgans Keeps Their Buy Rating on Cleanaway Waste Management (TSPCF)
In a report released today, Nathan Lead from Morgans maintained a Buy rating on Cleanaway Waste Management (TSPCF – Research Report), with a price target of A$2.98. The company's shares closed last Friday at $1.82.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Lead is a 3-star analyst with an average return of 1.7% and a 53.85% success rate. Lead covers the Industrials sector, focusing on stocks such as Dalrymple Bay Infrastructure Ltd., Aurizon Holdings, and Cleanaway Waste Management.
Cleanaway Waste Management has an analyst consensus of Strong Buy, with a price target consensus of $1.95.
Based on Cleanaway Waste Management's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.94 billion and a net profit of $73.3 million. In comparison, last year the company earned a revenue of $1.84 billion and had a net profit of $73.2 million
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Carnival Stock (CCL) Dips on Loyalty Program Changes
Carnival (CCL) stock slipped on Monday after the cruise line company announced controversial changes to its loyalty program. The company will nix its Very Important Fun Person (VIFP) program next year in favor of a new rewards program. This issue with this is that it will change how passengers earn rewards. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The new program will allow customers to earn benefits over two years, and retain those benefits for another two. For comparison, the current loyalty program offered benefits for life. Another change is how points are earned: the new system offers points for money spent, while the current one gives points based on nights booked. These changes are designed to limit the number of guests who have access to the highest level of rewards. The decision to switch to this system was made after the current loyalty program become inflated with members who have benefits for life. While the new system alleviates this issue, it isn't going over well with loyalty members. Carnival Stock Ratings and Movement Today James Hardiman. This suggests a possible 19.91% upside for CCL stock. CCL shares were down 1.72% on Monday following the new loyalty program reveal. Investors will note the stock is also down 6.4% year-to-date but has rallied 45.03% over the past 12 months. Is CCL Stock a Buy, Sell, or Hold? Turning to Wall Street, the analysts' consensus rating for Carnival is Moderate Buy, based on 13 Buy and five Hold ratings over the past three months. With that comes an average CCL stock price target of $28.73, representing a potential 23.04% upside for the shares.
Business Insider
an hour ago
- Business Insider
Why Is Impact BioMedical Stock (IBO) Up 200% Today?
Impact BioMedical (IBO) stock skyrocketed on Monday after the specialty biopharmaceutical and consumer healthcare company announced a merger agreement with Hong Kong-based pharmaceutical company Dr Ashleys Limited. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter These two companies have agreed to a reverse merger that will see Dr Ashleys Limited acquire Impact BioMedical, with the combined company trading under the Dr Ashleys Limited name. The Dr Ashleys management team will lead the combined company and will also create a new Board of Directors. Dr. Kanans Visvanats, director of Dr. Ashleys Limited, said, 'By integrating Impact Biomedical's impressive IP portfolio into our R&D efforts, we are poised to accelerate the development of groundbreaking therapies and expand our Impact on global health.' IBO Stock Movement Today
Business Insider
an hour ago
- Business Insider
Why Investors Should Reconsider Buying the Dip on Apple Stock (AAPL)
The year 2025, so far, hasn't been kind to Apple (AAPL) shareholders. The stock is trading below the $200 mark—about 25% off its all-time highs—making it the worst performer among the top seven tech stocks right now. This is a sharp contrast to the 22% total annualized returns Apple has delivered to shareholders over the past decade. Confident Investing Starts Here: While the recent bearishness isn't entirely unjustified — higher import fees are putting pressure on Apple's product margins, and sticky interest rates continue to weigh on consumer spending — I don't believe the stock is doomed for an extended correction. Historically, Apple has proven to be a great stock to own during periods of relative weakness like this, especially when valuations reset to more reasonable levels. That said, when it comes to high-quality stocks like AAPL, buying just because momentum looks weak isn't always the best strategy. For now, until the trends start to improve, I remain Neutral on AAPL stock. Understanding Apple's Position Amid Trade War Challenges Among the Magnificent 7 stocks, Apple's recent performance clearly reflects that markets view the company's thesis as one of the most fragile, mainly due to growing concerns around the ongoing trade war. The possibility of new tariffs on imported products resurfaced after the U.S. president threatened to impose a 25% tariff on iPhones manufactured outside the U.S. No doubt, this would be a blow to Apple's bullish case. Growth estimates are likely to be revised downward for the coming quarters—and possibly even years. However, if we step back and look at the bigger picture, these fears might actually be somewhat exaggerated, as TipRanks' risk analysis shows. For one, history shows that tariff threats are often more a political negotiation tool than something that is actually enforced. Additionally, under the highly efficient leadership of CEO Tim Cook, Apple has consistently demonstrated its ability to navigate supply chain challenges. We saw this play out back in 2018-2019, during Trump's first administration, when the U.S.-China trade war intensified. Apple responded quickly by expanding its production outside of China, significantly reducing its reliance on the country. Approximately 75% of Apple's revenue still comes from hardware, which is more susceptible to tariff risks. But here's the other side of the coin: Apple's services segment has grown massively and now accounts for around 40% of operating profit. This part of the business—driven by recurring revenue streams like the App Store and licensing deals (think Google) — is far less exposed to trade war impacts. In fact, I believe the services business is still underrated by the market and remains one of Apple's most powerful growth engines today. The Valuation Story Behind Apple's Recent Moves Naturally, when tariffs threaten to impact Apple's core business, combined with a broader 'crash correction' where markets rush for cash and liquidity, and the stock is trading at elevated valuation multiples, the outcome tends to be a bearish reaction. Currently, Apple trades at 27.3x forward earnings, which is significantly below the 36x peak reached in January and also below its 12-month average of 31x. While long-term EPS growth expectations aren't particularly exciting at around 10% CAGR, a PEG ratio of 2.5 honestly doesn't seem outrageous for a company with fundamentals as strong as Apple's. But the key point in this case may be that Apple shouldn't be trading at cheap multiples and probably never will, simply because it's a company with a historically low risk of underperformance. While tariffs might seem like a threat, as I've highlighted before, Apple has faced similar headwinds not long ago and managed to navigate them successfully. After all, we're talking about a business with one of the strongest brands and the highest customer loyalty in the world. And when the numbers are crunched, Apple's services segment alone is arguably worth $1.7 trillion—that's more than half of the company's current market cap. Why 'Buy Low, Sell High' Isn't Always Right Although it may seem counterintuitive, I tend to believe that when it comes to high-quality stocks, the old saying 'buy low, sell high' is somewhat of a misnomer, mainly because no one actually knows where 'low' and 'high' truly are. If you think about it, 'sell high' would've meant selling AAPL (or any other high-quality tech name like MSFT, AMZN, and NVDA) multiple times over the past decade, expecting some massive correction that, honestly, either never came or only briefly happened. Meanwhile, you would have missed out on a ton of upside. That said, it's pretty well known that great stocks—the kind that isn't super cyclical and has rock-solid fundamentals (like Apple)—tend to perform better on a risk-adjusted basis when they're trending higher, not when they're at some mythical 'bottom' or during ugly corrections. And honestly, that pretty much describes where AAPL is right now: stuck in a weak momentum phase. The reality is that when high-quality stocks are in a clear uptrend—meaning trading above long-term moving averages like the 200-day—they deliver lower drawdowns, better Sharpe ratios, and just generally smoother, more consistent returns. In Apple's case, sitting at $198 per share, it's well below its 200-day moving average of $223.50, which is a clear signal of bearish momentum. My take is that I would be comfortable going heavy on the stock only if it starts showing a steady recovery. Otherwise, simply stepping aside when the chart is falling apart may be the wisest course of action. Is Apple a Buy, Sell, or Hold? While there's certainly room for skepticism, the consensus among AAPL analysts remains mostly bullish. Out of 29 experts covering the stock, 16 rate it a Buy, nine rate it a Hold, and only four recommend Sell. AAPL's average price target stands at $226.94, suggesting about 15% upside from the current share price. Don't Buy AAPL's Dip Just Yet Apple is in bear territory—and in my view, for somewhat justified reasons. As a high-quality stock with pristine business fundamentals (both subjectively and quantitatively), many Apple bulls may be tempted to jump in on the 'buy the dip' opportunity as valuations fall from their peaks. And while that approach makes sense, the reality is that no one ever truly knows how low Apple's valuation can go. Historically, high-quality stocks tend to behave better when they're near a peak rather than stuck in the middle of corrections. That's why, personally, I would prefer to wait for more apparent signs of a reversal. Even if that means giving up part of the upside, the trade-off is entering with a better risk-adjusted setup backed by stronger technical confirmation. Bottom line, I believe Apple is a Hold for now.
